Medical Oncology

Doç. Dr. Muhammed Mustafa Atcı

Doctor and researcher Liv Hospital Topkapı İstanbul
Breast NeoplasmsLung NeoplasmsColorectal NeoplasmsStomach NeoplasmsCarcinoma, Non-Small-Cell LungLiver NeoplasmsRectal NeoplasmsCarcinoma, Renal CellKidney NeoplasmsColonic NeoplasmsEsophageal NeoplasmsPancreatic NeoplasmsNeoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 9 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Lung Neoplasms 9 publications
  • Colorectal Neoplasms 4 publications
  • Stomach Neoplasms 4 publications
  • Carcinoma, Non-Small-Cell Lung 4 publications
  • Liver Neoplasms 3 publications
  • Rectal Neoplasms 3 publications
  • Carcinoma, Renal Cell 2 publications
  • Kidney Neoplasms 2 publications
  • Colonic Neoplasms 2 publications
  • Esophageal Neoplasms 2 publications
  • Pancreatic Neoplasms 2 publications
  • Neoplasms 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest the doctor lists on their own profile on the institution’s website. Source: livhospital.com.

  • Akciğer Kanseri
  • Meme Kanseri
  • Başboyun kanserleri
  • Gis Maligniteleri
  • Malign Melanom

CV

Education and experience

From source

Experience

  • Experience24.08.2015 – 05.09.2017 | Uzman Doktor, Tokat Devlet Hastanesi, Türkiyelivhospital.com
  • Experience15.09.2017 – 01.10.2018 | Uzman Doktor, İstanbul Haseki Eğitim ve Araştırma Hastanesi, Türkiye (Sağlık Bakanlığı)livhospital.com
  • Experience01.11.2018 – 02.11.2021 | Yandal Asistanı, Sağlık Bakanlığı Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesi, Türkiyelivhospital.com
  • Experience2023 – 2025 | Tıbbi Onkoloji Yandal Doçenti, Eğitim Sorumlusu, Sağlık Bakanlığı Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesilivhospital.com

Education

  • Education2003 – 2009 | İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi – Tıp Eğitimilivhospital.com
  • Education2011 – 2015 | Sağlık Bilimleri Üniversitesi, İstanbul Şişli Hamidiye Etfal Sağlık Uygulama ve Araştırma Merkezi – İç Hastalıkları Anabilim Dalılivhospital.com
  • Education2018 – 2021 | Sağlık Bilimleri Üniversitesi, İstanbul Prof. Dr. Cemil Taşcıoğlu Şehir Sağlık Uygulama ve Araştırma Merkezi – İç Hastalıkları Anabilim Dalı, Onkoloji Bilim Dalılivhospital.com

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologylivhospital.comFrom source
  • InstitutionLiv Hospital Topkapılivhospital.comFrom source
  • Area of workBreast NeoplasmsExtracted from 9 publications · Model version —From source
  • Publications104 publicationsOpenAlexFrom source
  • Last synchronised4 November 2026 21:05https://www.livhospital.com/doc-dr-muhammed-mustafa-aticilivhospital.com

Scientific work

Publications on Breast Neoplasms

104 publications
Publications by year Most: 15, in 2021
  1. 2019: 2 publications
  2. 2020: 5 publications
  3. 2021: 15 publications
  4. 2022: 15 publications
  5. 2023: 5 publications
  6. 2024: 5 publications
  7. 2025: 10 publications
  8. 2026: 13 publications

  1. Perioperative FLOT versus Definitive 50.4 Gy Chemoradiotherapy in Siewert II Esophagogastric Junction Adenocarcinoma: A Multicenter Retrospective Cohort Study

    Cancer Management and Research, 2026

    DOI 10.2147/cmar.s583473 PMID 42038552 Open-access full textSource: OpenAlex

  2. Inflammatory and Nutritional Indices as Prognostic Markers in Locally Advanced Gastric Cancer Treated with Neoadjuvant FLOT: A Retrospective Multicenter Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15072574 PMID 41976874 3 citations (Europe PMC) Open-access full textSource: OpenAlex

  3. Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-15725-9 PMID 41691201 Open-access full textSource: OpenAlex

  4. Expression and prognostic importance of lymphocyte activation gene 3 and CD73 in advanced or metastatic hepatocellular carcinoma

    Journal of International Medical Research, 2026

    DOI 10.1177/03000605251386599 PMID 41521150 Open-access full textSource: OpenAlex

  5. Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature

    Clinical Genitourinary Cancer, 2026

    DOI 10.1016/j.clgc.2026.102594 PMID 42349378 Source: OpenAlex

  6. De-escalated chemotherapy and endocrine therapy outcomes in young women with stage I HR+/HER2+ breast cancer: An international real-world study

    The Breast, 2026

    DOI 10.1016/j.breast.2026.104838 PMID 42309024 Open-access full textSource: OpenAlex

  7. Neoadjuvant Pertuzumab in Breast Cancer and Associated Prognostic Factors

    European Archives of Medical Research, 2026

    DOI 10.14744/eamr.2025.35682 Open-access full textSource: OpenAlex

  8. Bevacizumab or Aflibercept in Combination with Second-Line FOLFIRI after Progression on FOLFOX Plus Bevacizumab in Metastatic Colorectal Cancer: A Comparative Study

    Journal of Cancer, 2026

    DOI 10.7150/jca.138530 PMID 42807710 Open-access full textSource: OpenAlex

  9. Prognostic factors and survival outcomes in older adults with extensive-stage small cell lung cancer: A multicenter retrospective cohort study

    Medicine, 2026

    DOI 10.1097/md.0000000000048711 PMID 42116366 Open-access full textSource: OpenAlex

  10. Prognostic value of PSMA PET–derived tumor volume in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide

    Cancer Imaging, 2026

    DOI 10.1186/s40644-026-01036-6 PMID 42063136 Open-access full textSource: OpenAlex

View all 104 publications